ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,244.80
1.57%
다우존스 지수
38,239.66
0.40%
Bitcoin
63,210.43
-0.83%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Vanda Pharmaceuticals Inc (VNDA)

  7. Vanda Pharmaceuticals Inc (VNDA) 뉴스

VNDA Vanda Pharmaceuticals Inc

4.5199
0.0399 (0.89%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Vanda Pharmaceuticals Inc VNDA 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.0399 0.89% 4.5199 09:00:00
개장가 저가 고가 종가 전일 종가
4.57 4.45 4.625 4.62 4.48
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
25/04/202421:05GLOBEShareholder Capital Delivers Letter to Independent Members..
23/04/202408:13PRNUSVanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial..
17/04/202423:21PRNUSVanda Pharmaceuticals Adopts Limited Duration Stockholder..
17/04/202422:02PRNUSVanda Pharmaceuticals Confirms Rejection of Unsolicited..
03/04/202423:25APSBiotech Catches Major Premarket Bid Following FDA Approval
03/04/202407:10PRNUSVanda Pharmaceuticals' Fanapt® (iloperidone) Receives U.S...
08/03/202406:31EDGAR2Form 8-K - Current report
07/03/202406:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/03/202406:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/03/202406:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/03/202406:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/03/202406:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202421:00PRNUSVanda Pharmaceuticals Announces FDA Update for supplemental..
05/03/202411:14EDGAR2Form 144 - Report of proposed sale of securities
05/03/202411:12EDGAR2Form 144 - Report of proposed sale of securities
05/03/202411:10EDGAR2Form 144 - Report of proposed sale of securities
05/03/202411:08EDGAR2Form 144 - Report of proposed sale of securities
05/03/202411:06EDGAR2Form 144 - Report of proposed sale of securities
22/02/202406:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202406:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202406:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202406:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202406:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/02/202406:32EDGAR2Form 8-K - Current report
17/02/202406:31EDGAR2Form 8-K/A - Current report: [Amend]
08/02/202421:19EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
08/02/202406:07EDGAR2Form 8-K - Current report
08/02/202406:02PRNUSVanda Pharmaceuticals Reports Fourth Quarter and Full Year..
06/02/202406:34EDGAR2Form 8-K - Current report
05/02/202422:00PRNUSVanda Pharmaceuticals Announces FDA Update for supplemental..
01/02/202406:30PRNUSVanda Pharmaceuticals to Announce Fourth Quarter and Full..
31/01/202423:00PRNUSVanda Pharmaceuticals Receives FDA Approval to Proceed with..
31/01/202402:35PRNUSCourt Orders FDA to Resolve Vanda Pharmaceuticals' Jet Lag..
30/01/202409:00PRNUSCourt Orders FDA to Resolve Vanda Pharmaceuticals' Jet Lag..
26/01/202412:05PRNUSVanda Pharmaceuticals Announces a U.S. Patent Allowance for..
26/01/202403:07PRNUSVanda Pharmaceuticals announces the publication of an..
24/01/202401:52EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
23/01/202423:15PRNUSVanda Pharmaceuticals Receives FDA Approval to Proceed with..
20/01/202406:57DJNVanda Pharma's Trade Secrets Suit Against FDA Moves Forward
20/01/202405:56PRNUSFederal Court Allows Vanda Pharmaceuticals' Lawsuit to..
18/01/202405:46PRNUSVanda Pharmaceuticals announces the publication of Efficacy..
13/01/202402:21PRNUSVanda Pharmaceuticals Comments on FDA's Recently Announced..
05/01/202406:30PRNUSVanda Pharmaceuticals Announces Participation in the J.P...
16/12/202306:15EDGAR2Form 8-K - Current report
08/12/202307:19EDGAR2Form 8-K - Current report
07/12/202321:00PRNUSVanda Pharmaceuticals Acquires U.S. and Canadian Rights to..
05/12/202320:23DJNVanda Pharmaceuticals Shares Rise Premarket on FDA Review of..
05/12/202308:45DJNVanda Pharma Says FDA Accepts New Drug Application for..
05/12/202308:00PRNUSVanda Pharmaceuticals Announces that U.S. Food and Drug..
10/11/202306:30PRNUSVanda Pharmaceuticals Announces Participation at November..

최근 히스토리

NASDAQ
VNDA
Vanda Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유